These data spotlight PAI-1 as an attractive therapeutic target for the mitigation of lung fibrosis, but only a few studies have interrogated the efficacy of small molecule PAI-1 inhibitors in animal models of these diseases. Here, SERPINE1 is linked to pulmonary fibrosis.